The Patent Finder

Terms ending in 2035

F. Hoffmann-La Roche AG

Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,004,817Diazacarbazole Derivatives as Tau-Pet-Ligands
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 10,005,770Process for the Preparation of N-[(3-Aminooxetan-3-YL)METHYL]-2-(1,1-Dioxo-3,5-Dihydro-1,4-Benzothiazepin-4-YL)-6-Methyl-QUINAZOLIN-4-Amine
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 10,684,291Biomarkers for Risk Assessment and Treatment Monitoring in Heart Failure Patients Guided by Natriuretic Peptides
In force
 · High confidence
Roche Diagnostics Operations, Inc.In forceHigh confidence
US 12,117,454Biomarkers for Risk Assessment and Treatment Monitoring in Heart Failure Patients Guided by Natriuretic Peptides
In force
 · Low confidence
Roche Diagnostics International AGIn forceLow confidence
US 10,087,245Camelid Single-Domain Antibody Directed Against Phosphorylated Tau Proteins and Methods for Producing Conjugates Thereof
In force
 · High confidence
F. Hoffmann-La Roche AG, Institut Pasteur, Commissariat a l'Energie Atomique et aux Energies Alternatives and Centre National de la Recherche Scientifique (CNRS)In forceHigh confidence
US 10,538,582Camelid Single-Domain Antibody Directed Against Phosphorylated Tau Proteins and Methods for Producing Conjugates Thereof
In force
 · High confidence
Centre National de la Recherche Scientifique (CNRS)In forceHigh confidence
US 9,458,153Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 11,124,563Camelid Single-Domain Antibody Directed Against Phosphorylated Tau Proteins and Methods for Producing Conjugates Thereof
In force
 · Medium confidence
Centre National de la Recherche Scientifique (CNRS)In forceMedium confidence
US 9,957,266IMIDAZO[1,2-a]PYRIDIN-7-Amine
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 9,518,121ANTI-JAGGED1 Antibodies and Methods of Use
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
52 more term ends in 2035 · Pro
10 of 62 patents shown. Soonest term end first, then patent number.
Pro members see all 62.
Upgrade to Pro
13 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited